AstraZeneca has signed an AI-led research agreement with China's CSPC Pharmaceutical Group worth up to $5.3 billion, which ...

China attaches great importance to the development of AI and is advancing its integration into the real economy. Through the "AI Plus" initiative, China is driving the intelligent transformation of ...

British drugmaker AstraZeneca unveiled on Friday an AI-assisted research partnership with Chinese counterpart CSPC ...

Airlines prioritized surging e-commerce shipments on trans-Pacific and Asia-Europe routes over the past few years at the ...

NVIDIA expands across Europe with major AI infrastructure deals, focusing on sovereign AI to offset China losses and boost ...

That number falls short of Nvidia’s over 1 million China-specific H20 chips produced in the last nine months of 2024, ...

National security experts warn that Israel's attack on Iran shows why Chinese land and asset purchases in the U.S. pose a ...

Creating guardrails for AI can't wait, says Jake Sullivan, and the responsibility may ultimately fall on the shoulders of CEOs.

Friday’s deal with fits neatly within AstraZeneca’s business development strategy of upping investments in AI and in China.

Former Rep. Chris Stewart argues that the military needs to develop an edge in AI in order to be faster and smarter in the ...

Global demand for lithium is rapidly increasing due to the growth of electric vehicles, with current recycling rates of ...

The report noted that their responsibilities entail training AI in literary and artistic expression, enhancing the system's ...